Hyoscyamine Sulfate Tablet, Extended Release
Product Images NDC 39328-052

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hyoscyamine Sulfate (NDC 39328-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Patrin Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Patrin 01)

Chemical structure of hyoscyamine sulfate dihydrate, shown with the hyoscyamine molecule complexed with sulfate ions and water of hydration. The structure depicts the molecular arrangement relevant to the active pharmaceutical ingredient.*

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Hyoscyamine Sulfate Extended-Release Oral Tablets 0.375 mg per tablet in a package of 100 tablets. The label states the product is made in the USA and manufactured for Patrin Pharma, Inc. It includes dosage form, strength, storage instructions, and safety warnings, along with a barcode and NDC 39328-052-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.